SCHEMBL23946276

SCHEMBL23946276

C1CNC2C[C@@H]2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904117 1.00
SCHEMBL14828404 1.00
Hydrochloric Acid SCHEMBL18249041 0.97
SCHEMBL21276522 0.92 EPAS1 (0.42)
SCHEMBL3959007 0.92 EPAS1 (0.47)
SCHEMBL16878076 0.92
SCHEMBL14158242 0.90 EPAS1 (0.46)
SCHEMBL19541639 0.89 EPAS1 (0.48)
SCHEMBL16878031 0.89
SCHEMBL9834654 0.86 EPAS1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021211549-A1 KIF18A INHIBITORS FOR TREATMENT OF NEOPLASTIC DISEASES AMGEN INC. (US) 2021-10-21 WO disclosed